OR
Jordi Cruyff returning to Barcelona in advisor role
Jordi Cruyff, the son of Barcelona legend Johan, is returning to Camp Nou in an advisor role. The 47-year-old followed in the footsteps of his famous father when stepping out of the La Masia academy system in Catalunya. Much of his career was spent away from Barca, while he has also dabbled in coaching since hanging up his boots, but a familiar face now forms part of the restructuring work being put in behind the scenes by Blaugrana president Joan Laporta. Barca have said in a statement on the club’s official website: “FC Barcelona announces that Jordi Cruyff will join the football area of the Club and form part of the new organisational structure as of August 1. “Jordi Cruyff, who was a player in Barca’s youth teams and in the Barca first team from 1993 to 1996, returns in a strategic rol...
Donny van de Beek accused of making Manchester United move with ‘big boy’ attitude
Donny van de Beek has been accused by Marco van Basten of leaving Ajax for Manchester United with a “big boy” attitude, with the Dutch icon of the opinion that too many players depart Amsterdam believing that they have already made it. Van de Beek is among those to have been brought down to earth with a bump after leaving the comfort zone of life in his native Netherlands. A £35 million ($49m) switch to Old Trafford has not played out as planned for the 24-year-old midfielder, with only two Premier League starts taken in as questions are asked of his value to the Red Devils’ cause. Van Basten, who made his name at Ajax before going on to win the Ballon d’Or three times with AC Milan, told Ziggo Sport of Van de Beek and his struggles in England: “It just shows what a great life they have wh...
Zlatan Ibrahimovic: Brazil legend Ronaldo ‘the best player in history’
Milan star Zlatan Ibrahimovic has named Brazil legend Ronaldo as ‘the best player in history’. Ibrahimovic expressed his admiration towards the World Cup winner ahead of Milan’s Europa League clash with Red Star Belgrade on Thursday night, while putting him ahead of modern-day greats such as Lionel Messi and Cristiano Ronaldo in the all-time list of top players. The 39-year-old thinks Ronaldo Nazario, who inspired Brazil to World Cup glory in 2002, transcended the game with his unique talents and still stands out as the unrivalled master of the footballing craft to this day. Zlatan told Discovery Plus: “I don’t need to describe Ronaldo, ‘The Phenomenon’. “I always say you have the players that play the game, and the players that are the game. For me, Ronaldo is the game. When you watch him...
US election: Republicans hold back Democrats, narrowing path to Senate control
The battle for power in the Senate tightened into Wednesday as Democrats picked up a seat in Colorado, but suffered a setback in Alabama, and Republicans held their own in high-profile races in South Carolina, Iowa, Texas and Kansas, dramatically narrowing the political map. Republicans fought to retain their Senate majority by turning back a surge of Democrats challenging allies of President Donald Trump, and the Democrats’ various paths to seizing control were growing more limited. With several contests still too early to call, and one Georgia race heading to a January runoff, the final verdict is expected to drag on. Democrats gained a seat when ex-Gov. John Hickenlooper ousted GOP Sen. Cory Gardner in Colorado, a must-win to flip the Senate, but couldn’t hold on in Alabama, where forme...
Pfizer, BioNTech dose U.S first participants of trial coronavirus vaccine
Pfizer Inc. and BioNTech SE announced on Wednesday, May 6, 2020, that the first participants have been dosed in the U.S in the Phase 1/2 clinical trial for the BNT162 vaccine program to prevent COVID-19. The trial is part of a global development program, and the dosing of the first cohort in Germany was completed last week. The Phase 1/2 study is designed to determine the safety, immunogenicity and optimal dose level of four mRNA vaccine candidates evaluated in a single, continuous study. The dose level escalation portion (Stage 1) of the Phase 1/2 trial in the U.S will enrol up to 360 healthy subjects into two age cohorts (18-55 and 65-85 years of age). The first subjects immunized in Stage 1 of the study will be healthy adults 18-55 years of age. Older adults will only be immunized with ...
